SCHEMBL9921373

SCHEMBL9921373

COc1cccc(CCNc2ncnc3ccc(F)cc23)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 8/20 0.63
HTT P42858 2/20 0.61
CYP1A2 P05177 7/20 0.57
CYP3A4 P08684 7/20 0.57
CYP2D6 P10635 7/20 0.57
CYP2C19 P33261 6/20 0.57
USP2 O75604 6/20 0.57
ALDH1A1 P00352 6/20 0.57
HSD17B10 Q99714 5/20 0.57
EGFR P00533 2/20 0.57
MAPK1 P28482 6/20 0.56
LMNA P02545 6/20 0.56
CYP2C9 P11712 4/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
HIF1A Q16665 3/20 0.56
ALOX15 P16050 2/20 0.56
TSHR P16473 2/20 0.56
TP53 P04637 2/20 0.54
APP P05067 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9921432 0.94 CLK4 (0.62) CLK4HTTCYP1A2CYP3A4CYP2D6
SCHEMBL9921359 0.87 HTT (0.72) CLK4HTTEGFRMAPK1LMNA
SCHEMBL9921368 0.87 HTT (0.71) CLK4HTTEGFRMAPK1LMNA
SCHEMBL9921379 0.85 HTT (0.65) CLK4HTTCYP1A2CYP3A4CYP2D6
SCHEMBL9921378 0.83 HTT (0.63) CLK4HTTCYP1A2CYP3A4CYP2D6
SCHEMBL13191857 0.83 HTT (0.76) CLK4HTTEGFRMAPK1LMNA
SCHEMBL9921374 0.83 HTT (0.65) CLK4HTTCYP1A2CYP2D6EGFR
SCHEMBL9921431 0.82 PIK3CD (0.65) CLK4HTTLMNAUSP10PIK3C3
SCHEMBL13171070 0.81 CLK4 (0.59) CLK4HTTCYP1A2CYP3A4CYP2D6
SCHEMBL9921370 0.80 MAPK1 (0.59) CLK4HTTCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 CLK4 2339/4885HTT 4078/4885CYP1A2 4274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.